Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18–30 Years, 1994–2004
- 14 March 2007
- journal article
- Published by Springer Nature in Journal of Urban Health
- Vol. 84 (3) , 436-454
- https://doi.org/10.1007/s11524-007-9178-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Hepatitis C Virus Infection Among Injection Drug UsersEpidemiology, 2004
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD controlSexually Transmitted Infections, 2002
- Incidence and Risk Factors for Acute Hepatitis B in the United States, 1982–1998: Implications for Vaccination ProgramsThe Journal of Infectious Diseases, 2002
- Trends in HCV Prevalence Among Injecting Drug Users in Glasgow and Edinburgh During the Era of Needle/Syringe ExchangeScandinavian Journal of Infectious Diseases, 2001
- Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for interventionWestern Journal of Medicine, 2000
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997
- Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug UsersThe Journal of Infectious Diseases, 1996
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995
- Determinants of condom use among intravenous drug usersAIDS, 1993